In Reply - COVID-19, the Female Immune Advantage, and Cardiovascular Impact. Ritter O, Kararigas G. Mayo Clin Proc 2021;96:821-822.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ritter O, Kararigas G. In Reply - COVID-19, the Female Immune Advantage, and Cardiovascular Impact. Mayo Clin Proc 2021;96:821-822.
PMID: 33673934